Oncologix Tech, Inc.

OCLG

US68230M2098

Investment Holding Companies

Delayed OTC Markets Other stock markets 03:30:54 2024-05-07 pm EDT			5-day change	1st Jan Change
0.0002 ^USD	0.00%		0.00%	-92.00%

2022	DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction.	CI
2016	Oncologix Tech, Inc. Announces Management Changes	CI

Oncologix Tech, Inc. Announces Revenue Results for the Second Quarter and Half Year Ended February 28, 2014

April 21, 2014 at 12:38 pm EDT

Oncologix Tech, Inc. announced revenue results for the second quarter and half year ended February 28, 2014. Revenues for the quarter were $983,758 compared to zero revenues for the comparable period in fiscal 2013.

For the half year, the company reported revenue of $1,708,391 compared to zero revenues for the comparable periods in fiscal 2013.

Latest news about Oncologix Tech, Inc.

DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction.	22-05-01	CI
Oncologix Tech, Inc. Announces Management Changes	16-12-02	CI
Oncologix Tech, Inc. announced that it expects to receive $10 million in funding from Diversified Innovative Marketing Enterprises Limited	16-08-30	CI
Oncologix Tech, Inc. Announces Board Changes	16-06-24	CI
Oncologix Tech, Inc. Appoints Nikole Jessie as Director of Marketing and Public Relations	15-07-29	CI
Oncologix Tech Inc. Reports Revenue Results Third Quarter and Nine Months Ending May 31, 2015	15-07-21	CI
Oncologix Tech Eyes Acquisitions	15-07-21	CI
Oncologix Tech, Inc. Announces Earnings Results for the Second Quarter and Revenue Results for the Six Months Ended February 28, 2015; Provides Earnings Guidance for the Third Quarter and Full Year of Fiscal 2015	15-04-14	CI
Oncologix Seeks Acquisitions	15-04-14	CI
Oncologix Tech, Inc. Reports Earnings Results for the First Quarter Ending November 30, 2014; Provides Earnings Guidance for Second Quarter of 2015	15-01-16	CI
OCLG Mulls Acquisitions	14-12-30	CI
Oncologix Tech Mulls Acquisitions	14-10-07	CI
Oncologix Tech, Inc. acquired Esteemcare Inc. from Madhu Mathew Mammen and Imad Siddiqui for $0.5 million.	14-10-02	CI
Oncologix Tech, Inc. Announces Revenue Results for the Second Quarter and Half Year Ended February 28, 2014	14-04-21	CI
Oncologix Tech Inc. Closes $4,000,000 Revolving Credit Facility from Senior Lender	14-01-08	CI
Oncologix Tech, Inc. announced that it has received $0.04 million in funding.	13-08-07	CI
Oncologix Tech, Inc. acquired Angels of Mercy, Inc. from Clifford Haw and Jennifer Hebert for $0.65 million.	13-08-05	CI
Oncologix Tech, Inc. announced that it has received $0.1 million in funding	13-07-25	CI
Oncologix Tech, Inc. Elects Wayne Erwin as Chairman and CEO	13-04-02	CI
Oncologix Tech, Inc. acquired Dotolo Research Corporation from Clearview Medical, LLC.	13-03-27	CI
Oncologix Tech, Inc. Announces Management Changes	13-03-25	CI
Oncologix Tech, Inc. announced that it has received $0.12 million in funding.	13-01-08	CI
Oncologix Tech, Inc announced that it has received $0.02 million in funding.	12-10-16	CI
Oncologix Tech, Inc. announced that it has received $0.07 million in funding.	12-01-25	CI

Chart Oncologix Tech, Inc.

Duration

Period

More charts

Company Profile

Oncologix Tech, Inc. is a shell company. The Company is a non-operating holding Company. The Company has no operations. The Company seeks to acquire an operating company via reverse merger.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
ONCOLOGIX TECH, INC.	-92.00%	332K
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+188.53%	7.13B
CHURCHILL CAPITAL CORP VII	+2.10%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+26.12%	820M
ARES ACQUISITION CORPORATION II	+1.72%	664M
E7 GROUP	+5.92%	648M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies